Back
Verisk Analytics Vs. Ascendis Pharma AS Industry Stock Comparison
Buy
63
VRSK
Verisk Analytics
Last Price:
$285.13
Seasonality Move:
5.59%
Sell
45
ASND
Ascendis Pharma AS
Last Price:
$166.13
Seasonality Move:
-9.72%
Buy
63
Verisk Analytics (VRSK)
is a Buy
Is Verisk Analytics a Buy, Sell or Hold?
-
The current Verisk Analytics [VRSK] share price is $287.68. The Score for VRSK is 63, which is 26% above its historic median score of 50, and infers lower risk than normal.
-
VRSK is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
45
Ascendis Pharma AS (ASND)
is a Sell
Is Ascendis Pharma AS a Buy, Sell or Hold?
-
The current Ascendis Pharma AS [ASND] share price is $163.24. The Score for ASND is 45, which is 10% below its historic median score of 50, and infers higher risk than normal.
-
ASND is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
VRSK Stock Price Chart
What is Verisk Analytics's stock price today?
-
The Verisk Analytics share price today is $287.68Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and VRSK is experiencing slight selling pressure.
ASND Stock Price Chart
What is Ascendis Pharma AS's stock price today?
-
The Ascendis Pharma AS share price today is $163.24Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and ASND is experiencing selling pressure, which indicates risk of future bearish movement.
VRSK Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.25 | Sell |
| Relative Strength Index (14 RSI): | 44.53 | Sell |
| Chaikin Money Flow: | -23676 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (289.33 - 297.53) | Sell |
| Bollinger Bands (100): | (275.38 - 293.22) | Buy |
ASND Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 6.48 | Buy |
| Relative Strength Index (14 RSI): | 61.44 | Buy |
| Chaikin Money Flow: | -157690 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (140.84 - 161.98) | Buy |
| Bollinger Bands (100): | (124.23 - 147.13) | Buy |
VRSK Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 289.25 | Sell |
| 20-day SMA: | 293.3 | Sell |
| 50-day SMA: | 287.67 | Buy |
| 200-day SMA: | 276.6 | Buy |
| 8-day EMA: | 290.14 | Sell |
| 20-day EMA: | 291.5 | Sell |
| 50-day EMA: | 289 | Sell |
| 200-day EMA: | 274.79 | Buy |
ASND Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 158 | Buy |
| 20-day SMA: | 154.84 | Buy |
| 50-day SMA: | 140.45 | Buy |
| 200-day SMA: | 134.99 | Buy |
| 8-day EMA: | 159.99 | Buy |
| 20-day EMA: | 153.54 | Buy |
| 50-day EMA: | 144.83 | Buy |
| 200-day EMA: | 135.54 | Buy |
Verisk Analytics Earnings Growth & VRSK Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.18 per share, an increase next quarter of $0.10 per share, an increase this year of $0.40 per share, and an increase next year of $0.86 per share.
Ascendis Pharma AS Earnings Growth & ASND Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.82 per share, an increase next quarter of $0.04 per share, an increase this year of $3.21 per share, and an increase next year of $5.31 per share.
Verisk Analytics Technical Analysis
| Mar 6 | Mar 7 | Mar 11 | Mar 12 | Mar 13 | Mar 14 | Mar 17 | Mar 18 | Mar 19 | Mar 20 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar | ||||||||||
| 06 | 07 | 11 | 12 | 13 | 14 | 17 | 18 | 19 | 20 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Ascendis Pharma AS Technical Analysis
| Mar 6 | Mar 7 | Mar 11 | Mar 12 | Mar 13 | Mar 14 | Mar 17 | Mar 18 | Mar 19 | Mar 20 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar | ||||||||||
| 06 | 07 | 11 | 12 | 13 | 14 | 17 | 18 | 19 | 20 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||